Loading…
Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy
Annonaceous acetogenins (ACGs) have shown superior antitumor activity against a variety of cancer cell lines, but their clinical application has been limited by their poor solubility. In this study, ACGs-nanosuspensions (NSps) were successfully prepared by a precipitation ultrasonic method using mon...
Saved in:
Published in: | International journal of nanomedicine 2016-01, Vol.11, p.3239-3253 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-567aa441f9271ff8363917aeb89ff338bca020968ae7e80fafed687bfb465e153 |
---|---|
cites | |
container_end_page | 3253 |
container_issue | |
container_start_page | 3239 |
container_title | International journal of nanomedicine |
container_volume | 11 |
creator | Hong, Jingyi Li, Yanhong Li, Yijing Xiao, Yao Kuang, Haixue Wang, Xiangtao |
description | Annonaceous acetogenins (ACGs) have shown superior antitumor activity against a variety of cancer cell lines, but their clinical application has been limited by their poor solubility. In this study, ACGs-nanosuspensions (NSps) were successfully prepared by a precipitation ultrasonic method using monomethoxypoly (ethylene glycol)2000-poly (ε-caprolactone)2000 (mPEG2000-PCL2000) as a stabilizer. The resultant ACGs-NSps had a mean particle size of 123.2 nm, a zeta potential of -20.17 mV, and a high drug payload of 73.68%. ACGs-NSps were quite stable in various physiological solutions, and they exhibited sustained drug release. Compared to free drug, ACGs-NSps exhibited stronger cytotoxicity against 4T1, MCF-7, and HeLa cells. An in vivo real-time biodistribution investigation after labeling with 1,1'-dioctadecyltetramethyl indotricarbocyanine iodide, a noninvasive near-infrared fluorescence probe, demonstrated that ACGs-NSps could effectively accumulate in tumor. An in vivo antitumor activity study in 4T1 tumor-bearing mice revealed that ACGs-NSps achieved much better therapeutic efficacy than the traditional dosage form (oil solution) even at 1/10 of the dose (74.83% vs 45.53%, P |
doi_str_mv | 10.2147/IJN.S108143 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4957684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1809047822</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-567aa441f9271ff8363917aeb89ff338bca020968ae7e80fafed687bfb465e153</originalsourceid><addsrcrecordid>eNpdkUtr3DAUhUVpaR7tKvsg6KYQnOhlSe6iEIa8ypAG2q6FrJGmSm3JkewB59dHQ6Yh7erey_nu4UoHgCOMTglm4uzm2-3pD4wkZvQN2MdYyIogTN--6vfAQc73CNVC8uY92COCSU4J3Qeb8xBi0MbGKcNSxri2wYcMgw4xT3mwIftY5jzq1nf-0a5gO8O7xbK6u7iCbRfNHzjEbu5t-gKzXwfvvNFh7Gbo-yHFTVkoox-nPiZo3VY18wfwzuku24-7egh-XV78XFxXy-9XN4vzZWWoIGNVc6E1Y9g1RGDnJOW0wULbVjbOUSpboxFBDZfaCiuR086uuBStaxmvLa7pIfj67DtMbW9XxoYx6U4Nyfc6zSpqr_5Vgv-t1nGjWFMLLlkx-LwzSPFhsnlUvc_Gdp0O2y9TWKIGMSEJKein_9D7OKVQnqeKKnlNcbOlTp4pk2LOybqXYzBS2zxVyVPt8iz08ev7X9i_AdInKYqeXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2238653192</pqid></control><display><type>article</type><title>Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor & Francis Open Access Journals</source><creator>Hong, Jingyi ; Li, Yanhong ; Li, Yijing ; Xiao, Yao ; Kuang, Haixue ; Wang, Xiangtao</creator><creatorcontrib>Hong, Jingyi ; Li, Yanhong ; Li, Yijing ; Xiao, Yao ; Kuang, Haixue ; Wang, Xiangtao</creatorcontrib><description>Annonaceous acetogenins (ACGs) have shown superior antitumor activity against a variety of cancer cell lines, but their clinical application has been limited by their poor solubility. In this study, ACGs-nanosuspensions (NSps) were successfully prepared by a precipitation ultrasonic method using monomethoxypoly (ethylene glycol)2000-poly (ε-caprolactone)2000 (mPEG2000-PCL2000) as a stabilizer. The resultant ACGs-NSps had a mean particle size of 123.2 nm, a zeta potential of -20.17 mV, and a high drug payload of 73.68%. ACGs-NSps were quite stable in various physiological solutions, and they exhibited sustained drug release. Compared to free drug, ACGs-NSps exhibited stronger cytotoxicity against 4T1, MCF-7, and HeLa cells. An in vivo real-time biodistribution investigation after labeling with 1,1'-dioctadecyltetramethyl indotricarbocyanine iodide, a noninvasive near-infrared fluorescence probe, demonstrated that ACGs-NSps could effectively accumulate in tumor. An in vivo antitumor activity study in 4T1 tumor-bearing mice revealed that ACGs-NSps achieved much better therapeutic efficacy than the traditional dosage form (oil solution) even at 1/10 of the dose (74.83% vs 45.53%, P<0.05), demonstrating that NSp was a good dosage form for ACGs to treat cancer.</description><identifier>ISSN: 1178-2013</identifier><identifier>ISSN: 1176-9114</identifier><identifier>EISSN: 1178-2013</identifier><identifier>DOI: 10.2147/IJN.S108143</identifier><identifier>PMID: 27486323</identifier><language>eng</language><publisher>New Zealand: Taylor & Francis Ltd</publisher><subject>Acetogenins - pharmacology ; Animals ; Antineoplastic Agents - pharmacology ; Bioavailability ; Breast cancer ; Cancer therapies ; Cell Death - drug effects ; Cell Proliferation - drug effects ; Drug delivery systems ; Drug dosages ; Drug Liberation ; Drug resistance ; Experiments ; Female ; HeLa Cells ; Herbal medicine ; Humans ; Inhibitory Concentration 50 ; Laboratory animals ; Liver cancer ; MCF-7 Cells ; Mice, Inbred BALB C ; Nanoparticles ; Nanoparticles - chemistry ; Original Research ; Particle Size ; Penicillin ; Polyesters - chemistry ; Polyethylene Glycols - chemistry ; Quantitative analysis ; Suspensions ; Tissue Distribution - drug effects ; Treatment Outcome</subject><ispartof>International journal of nanomedicine, 2016-01, Vol.11, p.3239-3253</ispartof><rights>2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Hong et al. This work is published and licensed by Dove Medical Press Limited 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-567aa441f9271ff8363917aeb89ff338bca020968ae7e80fafed687bfb465e153</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2238653192/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2238653192?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27486323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hong, Jingyi</creatorcontrib><creatorcontrib>Li, Yanhong</creatorcontrib><creatorcontrib>Li, Yijing</creatorcontrib><creatorcontrib>Xiao, Yao</creatorcontrib><creatorcontrib>Kuang, Haixue</creatorcontrib><creatorcontrib>Wang, Xiangtao</creatorcontrib><title>Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy</title><title>International journal of nanomedicine</title><addtitle>Int J Nanomedicine</addtitle><description>Annonaceous acetogenins (ACGs) have shown superior antitumor activity against a variety of cancer cell lines, but their clinical application has been limited by their poor solubility. In this study, ACGs-nanosuspensions (NSps) were successfully prepared by a precipitation ultrasonic method using monomethoxypoly (ethylene glycol)2000-poly (ε-caprolactone)2000 (mPEG2000-PCL2000) as a stabilizer. The resultant ACGs-NSps had a mean particle size of 123.2 nm, a zeta potential of -20.17 mV, and a high drug payload of 73.68%. ACGs-NSps were quite stable in various physiological solutions, and they exhibited sustained drug release. Compared to free drug, ACGs-NSps exhibited stronger cytotoxicity against 4T1, MCF-7, and HeLa cells. An in vivo real-time biodistribution investigation after labeling with 1,1'-dioctadecyltetramethyl indotricarbocyanine iodide, a noninvasive near-infrared fluorescence probe, demonstrated that ACGs-NSps could effectively accumulate in tumor. An in vivo antitumor activity study in 4T1 tumor-bearing mice revealed that ACGs-NSps achieved much better therapeutic efficacy than the traditional dosage form (oil solution) even at 1/10 of the dose (74.83% vs 45.53%, P<0.05), demonstrating that NSp was a good dosage form for ACGs to treat cancer.</description><subject>Acetogenins - pharmacology</subject><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Bioavailability</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Cell Death - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Drug delivery systems</subject><subject>Drug dosages</subject><subject>Drug Liberation</subject><subject>Drug resistance</subject><subject>Experiments</subject><subject>Female</subject><subject>HeLa Cells</subject><subject>Herbal medicine</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Laboratory animals</subject><subject>Liver cancer</subject><subject>MCF-7 Cells</subject><subject>Mice, Inbred BALB C</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Original Research</subject><subject>Particle Size</subject><subject>Penicillin</subject><subject>Polyesters - chemistry</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Quantitative analysis</subject><subject>Suspensions</subject><subject>Tissue Distribution - drug effects</subject><subject>Treatment Outcome</subject><issn>1178-2013</issn><issn>1176-9114</issn><issn>1178-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUtr3DAUhUVpaR7tKvsg6KYQnOhlSe6iEIa8ypAG2q6FrJGmSm3JkewB59dHQ6Yh7erey_nu4UoHgCOMTglm4uzm2-3pD4wkZvQN2MdYyIogTN--6vfAQc73CNVC8uY92COCSU4J3Qeb8xBi0MbGKcNSxri2wYcMgw4xT3mwIftY5jzq1nf-0a5gO8O7xbK6u7iCbRfNHzjEbu5t-gKzXwfvvNFh7Gbo-yHFTVkoox-nPiZo3VY18wfwzuku24-7egh-XV78XFxXy-9XN4vzZWWoIGNVc6E1Y9g1RGDnJOW0wULbVjbOUSpboxFBDZfaCiuR086uuBStaxmvLa7pIfj67DtMbW9XxoYx6U4Nyfc6zSpqr_5Vgv-t1nGjWFMLLlkx-LwzSPFhsnlUvc_Gdp0O2y9TWKIGMSEJKein_9D7OKVQnqeKKnlNcbOlTp4pk2LOybqXYzBS2zxVyVPt8iz08ev7X9i_AdInKYqeXg</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Hong, Jingyi</creator><creator>Li, Yanhong</creator><creator>Li, Yijing</creator><creator>Xiao, Yao</creator><creator>Kuang, Haixue</creator><creator>Wang, Xiangtao</creator><general>Taylor & Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy</title><author>Hong, Jingyi ; Li, Yanhong ; Li, Yijing ; Xiao, Yao ; Kuang, Haixue ; Wang, Xiangtao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-567aa441f9271ff8363917aeb89ff338bca020968ae7e80fafed687bfb465e153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acetogenins - pharmacology</topic><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Bioavailability</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Cell Death - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Drug delivery systems</topic><topic>Drug dosages</topic><topic>Drug Liberation</topic><topic>Drug resistance</topic><topic>Experiments</topic><topic>Female</topic><topic>HeLa Cells</topic><topic>Herbal medicine</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Laboratory animals</topic><topic>Liver cancer</topic><topic>MCF-7 Cells</topic><topic>Mice, Inbred BALB C</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Original Research</topic><topic>Particle Size</topic><topic>Penicillin</topic><topic>Polyesters - chemistry</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Quantitative analysis</topic><topic>Suspensions</topic><topic>Tissue Distribution - drug effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hong, Jingyi</creatorcontrib><creatorcontrib>Li, Yanhong</creatorcontrib><creatorcontrib>Li, Yijing</creatorcontrib><creatorcontrib>Xiao, Yao</creatorcontrib><creatorcontrib>Kuang, Haixue</creatorcontrib><creatorcontrib>Wang, Xiangtao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hong, Jingyi</au><au>Li, Yanhong</au><au>Li, Yijing</au><au>Xiao, Yao</au><au>Kuang, Haixue</au><au>Wang, Xiangtao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy</atitle><jtitle>International journal of nanomedicine</jtitle><addtitle>Int J Nanomedicine</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>11</volume><spage>3239</spage><epage>3253</epage><pages>3239-3253</pages><issn>1178-2013</issn><issn>1176-9114</issn><eissn>1178-2013</eissn><abstract>Annonaceous acetogenins (ACGs) have shown superior antitumor activity against a variety of cancer cell lines, but their clinical application has been limited by their poor solubility. In this study, ACGs-nanosuspensions (NSps) were successfully prepared by a precipitation ultrasonic method using monomethoxypoly (ethylene glycol)2000-poly (ε-caprolactone)2000 (mPEG2000-PCL2000) as a stabilizer. The resultant ACGs-NSps had a mean particle size of 123.2 nm, a zeta potential of -20.17 mV, and a high drug payload of 73.68%. ACGs-NSps were quite stable in various physiological solutions, and they exhibited sustained drug release. Compared to free drug, ACGs-NSps exhibited stronger cytotoxicity against 4T1, MCF-7, and HeLa cells. An in vivo real-time biodistribution investigation after labeling with 1,1'-dioctadecyltetramethyl indotricarbocyanine iodide, a noninvasive near-infrared fluorescence probe, demonstrated that ACGs-NSps could effectively accumulate in tumor. An in vivo antitumor activity study in 4T1 tumor-bearing mice revealed that ACGs-NSps achieved much better therapeutic efficacy than the traditional dosage form (oil solution) even at 1/10 of the dose (74.83% vs 45.53%, P<0.05), demonstrating that NSp was a good dosage form for ACGs to treat cancer.</abstract><cop>New Zealand</cop><pub>Taylor & Francis Ltd</pub><pmid>27486323</pmid><doi>10.2147/IJN.S108143</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-2013 |
ispartof | International journal of nanomedicine, 2016-01, Vol.11, p.3239-3253 |
issn | 1178-2013 1176-9114 1178-2013 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4957684 |
source | Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis Open Access Journals |
subjects | Acetogenins - pharmacology Animals Antineoplastic Agents - pharmacology Bioavailability Breast cancer Cancer therapies Cell Death - drug effects Cell Proliferation - drug effects Drug delivery systems Drug dosages Drug Liberation Drug resistance Experiments Female HeLa Cells Herbal medicine Humans Inhibitory Concentration 50 Laboratory animals Liver cancer MCF-7 Cells Mice, Inbred BALB C Nanoparticles Nanoparticles - chemistry Original Research Particle Size Penicillin Polyesters - chemistry Polyethylene Glycols - chemistry Quantitative analysis Suspensions Tissue Distribution - drug effects Treatment Outcome |
title | Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A44%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Annonaceous%20acetogenins%20nanosuspensions%20stabilized%20by%20PCL-PEG%20block%20polymer:%20significantly%20improved%20antitumor%20efficacy&rft.jtitle=International%20journal%20of%20nanomedicine&rft.au=Hong,%20Jingyi&rft.date=2016-01-01&rft.volume=11&rft.spage=3239&rft.epage=3253&rft.pages=3239-3253&rft.issn=1178-2013&rft.eissn=1178-2013&rft_id=info:doi/10.2147/IJN.S108143&rft_dat=%3Cproquest_pubme%3E1809047822%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-567aa441f9271ff8363917aeb89ff338bca020968ae7e80fafed687bfb465e153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2238653192&rft_id=info:pmid/27486323&rfr_iscdi=true |